Capstone Investment Advisors
DNA icon

Capstone Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History

Capstone Investment Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,099
Closed -$242K – 1984
2024
Q2 		$242K Buy
18,099
+14,933
+472% +$446K 0.01% 1694
2024
Q1 		$147K Buy
+3,166
New +$164K ﹤0.01% 2077
2023
Q4 		– Sell
-1,743
Closed -$126K – 2178
2023
Q3 		$126K Buy
+1,743
New +$139K ﹤0.01% 1915
2021
Q4 		– Sell
-1,068
Closed -$495K – 1917
2021
Q3 		$495K Buy
+1,068
New +$520K 0.01% 1551

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return